EQT has agreed to acquire Range Resources in an all-stock transaction valued at $12.8 billion, a deal expected to create the largest natural gas producer in the United States. The merger, still pending shareholder and regulatory approvals, is anticipated to combine Range's asset base with EQT's natural gas platform. While EQT's CEO highlights the potential for the combined company to achieve profitability with natural gas prices below $2, the filing also outlines risks that could prevent the deal's completion.

This article reports on the filing of Form 8K by Agilent Technologies on November 12, 2026. The Form 8K is a crucial document that U.S. companies must file with the SEC to announce major events that shareholders should know about. The article provides the title and date of the filing, along with a generic image indicating Reuters as the source.

Colgate-Palmolive has agreed to a $930,000 settlement with the US Environmental Protection Agency (EPA) for failing to report numerous chemical substances imported between 2016 and 2019, violating the Toxic Substances Control Act (TSCA) Chemical Data Reporting (CDR) Rule. The company has since certified compliance and paid the penalty. The EPA emphasizes that data reporting is crucial for protecting human health and the environment, and worked with Colgate-Palmolive to ensure compliance.

Corteva Inc. (CTVA) reported third-quarter adjusted earnings of 6 cents a share, missing the 10-cent consensus, as net sales fell 9% to $1.59 billion. The company cut its full-year 2026 adjusted operating EPS guidance to 76-80 cents a share and EBITDA to $1.1 billion-$1.125 billion, citing a sharp deterioration in Brazil's crop protection market. This downturn, driven by farmer liquidity constraints and high interest rates, overshadowed solid growth in other regions, prompting Corteva to streamline its Crop Protection network.

The upcoming Anthropic IPO, with an expected valuation significantly higher than the combined value of Salesforce, ServiceNow, Adobe, Intuit, and Workday, raises concerns for incumbent software companies. Investors are questioning whether the AI agent model, which Anthropic champions, will shrink the "per seat" licensing model traditionally used by companies like Salesforce and ServiceNow. While these incumbents report continued growth in their seat-based sales and are partnering with Anthropic, the direct availability of the disruptor via an IPO may divert investment and further pressure their valuations.

Amgen's experimental drug, dazodalipeb, has shown promise as a first-in-class treatment for Sjögren’s disease, with positive Phase III results demonstrating significant improvements in systemic disease activity and self-reported dryness. The drug, acquired as part of the Horizon Pharma takeover, met its primary endpoint in two dosing regimens and was generally well-tolerated. This positions dazodalipeb as a strong contender in the race to market for Sjögren's, potentially outperforming competitor drugs currently under regulatory review.

JPMorgan Asset Management reported a 40% year-over-year increase in private wealth alternative assets in Asia-Pacific, driven by client interest in hedge funds, private equity, and infrastructure. This growth aligns with JPMorgan Chase's strategy to expand fee-based revenue within its asset and wealth management divisions. Investors are encouraged to monitor how this asset surge translates into fee growth, especially considering the outlook for higher expenses.

Joel Isaacson & Co. LLC increased its stake in Intel Corporation by 23.5% in the third quarter of 2026, acquiring an additional 12,121 shares to own a total of 63,702 shares valued at $7.66 million. Concurrently, Intel CEO Lip-Bu Tan purchased 150,000 shares for $9.71 million, boosting his direct holdings by 11.41%. The company's latest quarterly earnings exceeded EPS estimates, though revenue was slightly below forecasts, and analysts maintain a consensus "Hold" rating with an average price target of $97.42.

King Luther Capital Management Corp reduced its stake in Bank of America by 3.8% in the third quarter of 2026, selling 267,985 shares but still holding a significant position. Bank of America's recent earnings per share and revenue missed analyst expectations, although revenue did see a 3.2% year-over-year increase. Analysts maintain a "Moderate Buy" rating with an average price target of $62.48, and the company announced a quarterly dividend of $0.32 per share.

King Luther Capital Management Corp acquired a new position of 498,633 shares in Linde PLC, valued at approximately $236.7 million, making it their 23rd largest holding. Institutional investors collectively own 82.8% of Linde. The company recently reported strong quarterly earnings, beating analyst estimates, and declared a quarterly dividend of $1.60 per share, while some corporate insiders sold shares to cover tax obligations.